The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
复制标题
肿瘤浸润淋巴细胞在肝细胞癌中的预后价值:系统评价和荟萃分析
DOI:
10.1038/s41598-017-08128-1
复制
发表时间:
2017-08-08
影响因子:
4.6
通讯作者:
Ji, Lei
中科院分区:
文献类型:
--
作者:
Yao, Wei;He, Jun-chuang;Ji, Lei
Previous clinical studies have found that the levels of tumor-infiltrating lymphocytes (TILs) significantly correlated with prognosis in hepatocellular carcinoma (HCC). However, these conclusions and data remain controversial. We performed a systematic review and meta-analysis to assess the prognostic value and clinical utilization of TILs in patients with HCC. A total of 23 relevant studies of 3173 patients were included into our meta-analysis. The results demonstrated that high levels of CD8+and CD3+TILs had a better prognostic value on overall survival (OS), with HRs of 0.71 (P= 0.04) and 0.63 (P= 0.03), respectively, compared to low levels, as did high levels of CD8+, CD3+and CD4+TILs on disease/recurrence-free survival (DFS/RFS), with HRs of 0.66 (P= 0.01), 0.60 (P= 0.01) and 0.79 (P= 0.04), respectively. In contrast, high levels of FoxP3+TILs had a worse prognostic value on OS and DFS/RFS, with HRs of 2.06 (P< 0.00001) and 1.77 (P< 0.00001), respectively. The FoxP3+/CD4+and FoxP3+/CD8+ratios negatively correlated with OS and DFS/RFS. These findings suggest that TILs may serve as a prognostic biomarker in HCC. However, further research should be performed to clarify the clinical value of TILs in HCC.